尿中性粒细胞明胶酶相关脂质运载蛋白在糖尿病肾病早期诊断中的作用

doi:10.3969/j.issn.1673-8640.2015.06.010

摘要/Abstract

摘要： 目的

探讨尿中性粒细胞明胶酶脂质运载蛋白(NGAL)检测在糖尿病肾病(DN)诊断中的价值。

方法

收集糖尿病患者120例,根据24 h尿白蛋白排泄率(UAER)分为正常白蛋白尿(NA)组46例、微量蛋白尿(MA)组39例和临床肾病(CA)组35例;同期随机选取健康体检者50名作为正常对照(NC)组。应用酶联免疫吸附试验(ELISA)检测血清NGAL浓度,同时用碱性苦味酸法检测血清肌酐(SCr)浓度,用胶乳增强免疫浊度法检测血清半胱氨酸蛋白酶抑制剂C(Cys C)浓度,并进行比对分析。

结果

NA组尿NGAL水平明显高于NC组(P<0.05),而血清Cys C、SCr浓度2组之间差异无统计学意义(P>0.05)。MA组尿NGAL、血清Cys C水平明显高于NC组(P<0.05),SCr浓度2组之间差异无统计学意义(P>0.05)。CA组尿NGAL、血清Cys C、SCr水平均明显高于NC组(P<0.05)。

结论

尿NGAL是反映糖尿病早期肾损伤的良好指标。

关键词: 中性粒细胞明胶酶脂质运载蛋白, 半胱氨酸蛋白酶抑制剂C, 糖尿病肾病

Abstract: Objective

To investigate the significance of urinary neutrophil gelatinase-associated lipocalin (NGAL) in the diagnosis of diabetic nephropathy(DN).

Methods

A total of 120 diabetes mellitus patients were enrolled in the study. According to 24 h urine albumin excretion rate (UAER), the patients were classified into 3 groups, normal albuminuria (NA, 46 cases), microalbuminuria (MA, 39 cases) and clinical albuminuria (CA, 35 cases) groups. Another 50 healthy subjects were enrolled as normal control (NC) group. Serum NGAL concentrations were determined by enzyme-linked immunosorbent assay (ELISA). Serum creatinine (SCr) levels were determined by Jaffé reaction-rate method. Serum cystatin C (Cys C) concentrations were determined by latex-enhanced immune turbidity method. The results were analyzed comparatively.

Results

Urine NGAL concentration in NA group was significantly higher than that in NC group(P<0.05). No statistical significance was observed in concentrations of serum Cys C and SCr between NA and NC groups (P>0.05). Urinary NGAL and serum Cys C levels in MA group were significantly higher than those in NC grpup (P<0.05). No statistical significance of SCr was found between MA and NC groups (P>0.05). Urinary NGAL, serum Cys C and SCr levels in CA group were all significantly higher than those in NC group(P<0.05).

Conclusions

Urinary NGAL may be a biomarker for early renal damage in diabetes mellitus.

Key words: Neutrophil gelatinase-associated lipocalin, Cystatin C, Diabetic nephropathy

中图分类号:

R446.11

蔡雷鸣, 厉倩, 谭龙益. 尿中性粒细胞明胶酶相关脂质运载蛋白在糖尿病肾病早期诊断中的作用[J]. 检验医学, 2015, 30(6): 588-590.

CAI Leiming, LI Qian, TAN Longyi. The significance of urinary neutrophil gelatinase-associated lipocalin in the early diagnosis of diabetic nephropathy[J]. Laboratory Medicine, 2015, 30(6): 588-590.

图/表 1

参考文献 18

[1]	American Diabetes Association.Standards of medical care in diabetes-2011[J].Diabetes Care,2011,34(Suppl 1):S11-S61.
[2]	BARRATT J,TOPHAM P.Urine proteomics:the present and future of measuring urinary protein components in disease[J].CMAJ,2007,177(4):361-368.
[3]	BOLIGNANO D,LACQUANITI A,COPPOLINO G,et al.Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients[J].Kidney Blood Press Res,2009,32(2):91-98.
[4]	钱荣立. 糖尿病临床指南[M].北京:北京医科大学出版社,2001:7-12.
[5]	MORESCO RN, SANGOI MB, DE CARVALHO JA, et al.Diabetic nephropathy: traditional to proteomic markers[J]. Clin Chim Acta,2013,421:17-30.
[6]	KIM SS, SONG SH, KIM IJ, et al.Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients[J]. Diabetes Res Clin Pract,2012,97(2):251-257.
[7]	KIM SS, SONG SH, KIM IJ, et al.Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy[J]. Diabetes Care,2013,36(3):656-661.
[8]	HAN WK, WAGENER G, ZHU Y, et al.Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery[J]. Clin J Am Soc Nephrol,2009,4(5):873-882.
[9]	NIELSEN SE, REINHARD H, ZDUNEK D, et al.Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients[J]. Diabetes Res Clin Pract,2012,97(1):71-76.
[10]	YANG J,GOETZ D,LI JY,et al.An iron delivery pathway mediated by a lipocalin[J]. Mol Cell,2002,10(5):1045-1056.
[11]	BENNETT M, DENT CL, MA Q, et al.Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study[J]. Clin J Am Soc Nephrol,2008,3(3):665-673.
[12]	须静,胡晓波. 中性粒细胞明胶酶相关脂质运载蛋白的研究进展[J]. 检验医学,2012,27(10):871-876.
[13]	张群妹,郭庆合,鲁广建,等. 尿NGAL和血清Cys C在百草枯中毒患者急性早期肾损伤中的变化及意义[J]. 检验医学,2012,27(11):940-943.
[14]	邬叶红,赵荣平,徐燕萍. 尿中性粒细胞明胶酶相关性脂质运载蛋白检测对SLE肾病的临床意义[J]. 检验医学,2012,27(3):189-191.
[15]	蔡雷鸣,厉倩,金才峰,等. 血清中性粒细胞明胶酶相关脂质运载蛋白检测在急性肾功能损伤早期诊断中的临床意义[J]. 检验医学,2012,27(4):287-290.
[16]	胡雷光,朱立岳,谢芳,等. 尿NGAL在顺铂化疗肿瘤患者肾小管损伤中的临床意义探讨[J]. 检验医学,2013,28(5):374-378.
[17]	徐磊,徐晓萍,应春妹. NGAL在成人心脏术后急性肾损伤中的早期应用价值探讨[J]. 检验医学,2014,29(2):139-142.
[18]	张雅丽,崔丽艳,张捷. 中性粒细胞明胶酶相关脂质运载蛋白在急性肾损伤中的保护作用[J].检验医学,2015,30(1):80-84.

组别	例数	NGAL (μg/mL)	Cys C (mg/L)	SCr (μmol/L)
NA组	46	1.65±0.58	0.72±0.16	75.1±20.1
MA组	39	2.12±0.99	0.97±0.39	79.7±22.9
CA组	35	3.85±1.19	1.69±0.96	131.7±28.3
NC组	50	0.59±0.31	0.68±0.17	72.7±18.7

组别	例数	NGAL (μg/mL)	Cys C (mg/L)	SCr (μmol/L)
NA组	46	1.65±0.58	0.72±0.16	75.1±20.1
MA组	39	2.12±0.99	0.97±0.39	79.7±22.9
CA组	35	3.85±1.19	1.69±0.96	131.7±28.3
NC组	50	0.59±0.31	0.68±0.17	72.7±18.7